North America In Vitro Diagnostics Market Forecast up to 2025
- DG-023
- Pages: 116
- March 2019
- Total Views:1480
- Region : Global
- Infoholic Research
- Market Research Report

Details
Table Of Content
Scope
Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Total Addressable Market 10
1.3 Industry Trends 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 15
3.1 Market Definition-Infoholic Research 15
3.2 Advantages of IVD 15
3.3 Importance of IVD 15
3.4 Segmented Addressable Market 16
3.5 Trends in the North America In Vitro Diagnostics Market 16
3.6 Related Market 17
3.6.1 Medical Imaging 17
4 Market Outlook 19
4.1 Market Segmentation 19
4.2 PEST Analysis 19
4.3 Porter 5(Five) Forces 21
5 Market Characteristics 22
5.1 DRO-Market Dynamics 22
5.1.1 Drivers 23
5.1.1.1 Increasing incidence of lifestyle and chronic diseases 23
5.1.1.2 High adoption of POC testing 23
5.1.1.3 Growing demand for biomarker-based tests 24
5.1.2 Opportunities 24
5.1.2.1 Growing significance of companion diagnostics 24
5.1.2.2 Increasing number of strategic deals 24
5.1.3 Restraints 25
5.1.3.1 Stringent regulatory approval process 25
5.1.3.2 High cost of the test and unclear reimbursement policies 25
5.2 DRO-Impact Analysis 26
5.3 Key Stakeholders 26
6 Technology Types: Market Size and Analysis 28
6.1 Overview 28
6.2 Clinical Chemistry 29
6.3 Molecular Diagnostics 30
6.4 Immunoassay 32
6.5 Clinical Microbiology 33
6.6 Coagulation 34
6.7 Hematology 35
6.8 Others 36
7 Applications: Market Size and Analysis 37
7.1 Overview 37
7.2 Oncology 38
7.3 Infectious Disease 39
7.4 Diabetes 41
7.5 Cardiology 42
7.6 Nephrology 43
7.7 Autoimmune Disease 44
7.8 Others 45
8 End-users: Market Size and Analysis 47
8.1 Overview 47
8.2 Hospitals 47
8.3 Laboratories 48
8.4 Home Care 48
8.5 Academic and Research Institutes 49
8.6 Others 49
9 Country: Market Size and Analysis 50
9.1 Overview 50
9.2 US 51
9.3 Others 53
10 Competitive Landscape 55
10.1 Overview 55
11 Vendors Profile 57
11.1 F. Hoffmann-La Roche Ltd. 57
11.1.1 Overview 57
11.1.2 Business Units 63
11.1.3 Geographic Revenue 64
11.1.4 Business Focus 65
11.1.5 SWOT Analysis 65
11.1.6 Business Strategies 66
11.2 Thermo Fisher Scientific Inc. 67
11.2.1 Overview 67
11.2.2 Business Units 71
11.2.3 Geographic Revenue 72
11.2.4 Business Focus 73
11.2.5 SWOT Analysis 74
11.2.6 Business Strategies 74
11.3 Abbott Laboratories 75
11.3.1 Overview 75
11.3.2 Business Units 79
11.3.3 Geographic Revenue 81
11.3.4 Business Focus 81
11.3.5 SWOT Analysis 82
11.3.6 Business Strategies 82
11.4 Danaher Corporation 83
11.4.1 Overview 83
11.4.2 Business Units 87
11.4.3 Geographic Revenue 88
11.4.4 Business Focus 89
11.4.5 SWOT Analysis 90
11.4.6 Business Strategies 90
11.5 Sysmex Corporation 91
11.5.1 Overview 91
11.5.2 Business Units 93
11.5.3 Geographic Revenue 95
11.5.4 Business Focus 95
11.5.5 SWOT Analysis 96
11.5.6 Business Strategies 96
12 Companies to Watch For 98
12.1 bioMerieux S.A. 98
12.1.1 Overview 98
12.2 Beckton Dickinson and Company 100
12.2.1 Overview 100
12.3 Bio-Rad Laboratories 102
12.3.1 Overview 102
12.4 Qiagen N.V. 104
12.4.1 Overview 104
12.5 Siemens Healthineers 109
12.5.1 Overview 109
12.6 Ortho Clinical Diagnostics (Carlyle Group) 112
12.6.1 Overview 112
13 Annexure 115
13.1 Abbreviations 115
List Of Figure
Charts
CHART 1 RESEARCH METHODOLOGY OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 13
CHART 2 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET REVENUE, 2018-2025 (USD BILLION) 16
CHART 3 SEGMENTATION OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 19
CHART 4 PEST ANALYSIS OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 19
CHART 5 PORTER 5 FORCES ON NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 20
CHART 6 MARKET DYNAMICS-DRO ANALYSIS 22
CHART 7 DRO-IMPACT ANALYSIS OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 25
CHART 8 KEY STAKEHOLDERS 26
CHART 9 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPES, 2018 (%) 28
CHART 10 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPES, 2025 (%) 28
CHART 11 CLINICAL CHEMISTRY MARKET FORECAST, 2018-2025 (USD BILLION) 30
CHART 12 MOLECULAR DIAGNOSTICS MARKET FORECAST, 2018-2025 (USD BILLION) 31
CHART 13 IMMUNOASSAY MARKET FORECAST, 2018-2025 (USD BILLION) 32
CHART 14 CLINICAL MICROBIOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 33
CHART 15 COAGULATION MARKET FORECAST, 2018-2025 (USD BILLION) 34
CHART 16 HEMATOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 35
CHART 17 OTHER IVD TECHNOLOGIES MARKET FORECAST, 2018-2025 (USD BILLION) 36
CHART 18 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION,
2018 (%) 37
CHART 19 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION,
2025 (%) 37
CHART 20 ONCOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 39
CHART 21 INFECTIOUS DISEASE MARKET FORECAST, 2018-2025 (USD BILLION) 40
CHART 22 DIABETES MARKET FORECAST, 2018-2025 (USD BILLION) 41
CHART 23 CARDIOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 42
CHART 24 NEPHROLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 43
CHART 25 AUTOIMMUNE DISEASE MARKET FORECAST, 2018-2025 (USD BILLION) 44
CHART 26 OTHER APPLICATIONS MARKET FORECAST, 2018-2025 (USD BILLION) 45
CHART 27 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY END-USERS SEGMENTATION,
2018 (%) 46
CHART 28 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY GEOGRAPHICAL SEGMENTATION,
2018 (%) 49
CHART 29 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY GEOGRAPHICAL SEGMENTATION,
2025 (%) 49
CHART 30 IN VITRO DIAGNOSTICS MARKET REVENUE IN THE US, 2018-2025 (USD BILLION) 52
CHART 31 IN VITRO DIAGNOSTICS MARKET REVENUE IN OTHERS, 2018-2025 (USD BILLION) 53
CHART 32 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 64
CHART 33 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 64
CHART 34 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 65
CHART 35 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 66
CHART 36 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 72
CHART 37 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS 73
CHART 38 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC REVENUE 74
CHART 39 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 75
CHART 40 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 82
CHART 41 ABBOTT LABORATORIES: BUSINESS UNITS 83
CHART 42 ABBOTT LABORATORIES: GEOGRAPHIC REVENUE 84
CHART 43 ABBOTT LABORATORIES: SWOT ANALYSIS 85
CHART 44 DANAHER CORPORATION: OVERVIEW SNAPSHOT 90
CHART 45 DANAHER CORPORATION: BUSINESS UNITS 91
CHART 46 DANAHER CORPORATION: GEOGRAPHIC REVENUE 91
CHART 47 DANAHER CORPORATION: SWOT ANALYSIS 93
CHART 48 SYSMEX CORPORATION: OVERVIEW SNAPSHOT 96
CHART 49 SYSMEX CORPORATION: BUSINESS UNITS 96
CHART 50 SYSMEX CORPORATION: GEOGRAPHIC REVENUE 97
CHART 51 SYSMEX CORPORATION: SWOT ANALYSIS 98
List Of Table
Tables
TABLE 1 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET REVENUE BY COUNTRIES,
2018-2025 (USD BILLION) 50
TABLE 2 OTHER PROMINENT VENDORS IN THE NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 55
TABLE 3 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 57
TABLE 4 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 62
TABLE 5 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 68
TABLE 6 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS 70
TABLE 7 ABBOTT LABORATORIES: PRODUCT OFFERINGS 77
TABLE 8 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 78
TABLE 9 DANAHER CORPORATION: OFFERINGS 86
TABLE 10 DANAHER CORPORATION: RECENT DEVELOPMENTS 88
TABLE 11 SYSMEX CORPORATION: PRODUCT OFFERINGS 94
TABLE 12 SYSMEX CORPORATION: RECENT DEVELOPMENTS 95
TABLE 13 BIOMERIEUX S.A.: SNAPSHOT 100
TABLE 14 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 101
TABLE 15 BECTON DICKINSON AND COMPANY: SNAPSHOT 102
TABLE 16 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 103
TABLE 17 BIO-RAD LABORATORIES: SNAPSHOT 105
TABLE 18 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 106
TABLE 19 QIAGEN N.V.: SNAPSHOT 107
TABLE 20 QIAGEN N.V.: RECENT DEVELOPMENTS 107
TABLE 21 SIEMENS HEALTHINEERS: SNAPSHOT 113
TABLE 22 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 113
TABLE 23 ORTHO CLINICAL DIAGNOSTICS (CARLYLE GROUP): SNAPSHOT 116
TABLE 24 ORTHO CLINICAL DIAGNOSTICS (CARLYLE GROUP): RECENT DEVELOPMENTS 116
?
Licence Rights
"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Companies
Abbott Laboratories
Hoffmann-La Roche (Roche)
Thermo Fisher Scientific Inc.
Danaher Corporation
Sysmex Corporation
bioMerieux S.A.
Becton Dickinson and Company
Bio-Rad Laboratories
Qiagen N.V.
Siemens Healthineers
Ortho Clinical Diagnostics (Carlyle Group)
Company Profile
Company Profile Title
Scope
Table of Contents
1 Industry Outlook 9
1.1 Industry Overview 9
1.2 Total Addressable Market 10
1.3 Industry Trends 10
2 Report Outline 12
2.1 Report Scope 12
2.2 Report Summary 12
2.3 Research Methodology 13
2.4 Report Assumptions 13
3 Market Snapshot 15
3.1 Market Definition-Infoholic Research 15
3.2 Advantages of IVD 15
3.3 Importance of IVD 15
3.4 Segmented Addressable Market 16
3.5 Trends in the North America In Vitro Diagnostics Market 16
3.6 Related Market 17
3.6.1 Medical Imaging 17
4 Market Outlook 19
4.1 Market Segmentation 19
4.2 PEST Analysis 19
4.3 Porter 5(Five) Forces 21
5 Market Characteristics 22
5.1 DRO-Market Dynamics 22
5.1.1 Drivers 23
5.1.1.1 Increasing incidence of lifestyle and chronic diseases 23
5.1.1.2 High adoption of POC testing 23
5.1.1.3 Growing demand for biomarker-based tests 24
5.1.2 Opportunities 24
5.1.2.1 Growing significance of companion diagnostics 24
5.1.2.2 Increasing number of strategic deals 24
5.1.3 Restraints 25
5.1.3.1 Stringent regulatory approval process 25
5.1.3.2 High cost of the test and unclear reimbursement policies 25
5.2 DRO-Impact Analysis 26
5.3 Key Stakeholders 26
6 Technology Types: Market Size and Analysis 28
6.1 Overview 28
6.2 Clinical Chemistry 29
6.3 Molecular Diagnostics 30
6.4 Immunoassay 32
6.5 Clinical Microbiology 33
6.6 Coagulation 34
6.7 Hematology 35
6.8 Others 36
7 Applications: Market Size and Analysis 37
7.1 Overview 37
7.2 Oncology 38
7.3 Infectious Disease 39
7.4 Diabetes 41
7.5 Cardiology 42
7.6 Nephrology 43
7.7 Autoimmune Disease 44
7.8 Others 45
8 End-users: Market Size and Analysis 47
8.1 Overview 47
8.2 Hospitals 47
8.3 Laboratories 48
8.4 Home Care 48
8.5 Academic and Research Institutes 49
8.6 Others 49
9 Country: Market Size and Analysis 50
9.1 Overview 50
9.2 US 51
9.3 Others 53
10 Competitive Landscape 55
10.1 Overview 55
11 Vendors Profile 57
11.1 F. Hoffmann-La Roche Ltd. 57
11.1.1 Overview 57
11.1.2 Business Units 63
11.1.3 Geographic Revenue 64
11.1.4 Business Focus 65
11.1.5 SWOT Analysis 65
11.1.6 Business Strategies 66
11.2 Thermo Fisher Scientific Inc. 67
11.2.1 Overview 67
11.2.2 Business Units 71
11.2.3 Geographic Revenue 72
11.2.4 Business Focus 73
11.2.5 SWOT Analysis 74
11.2.6 Business Strategies 74
11.3 Abbott Laboratories 75
11.3.1 Overview 75
11.3.2 Business Units 79
11.3.3 Geographic Revenue 81
11.3.4 Business Focus 81
11.3.5 SWOT Analysis 82
11.3.6 Business Strategies 82
11.4 Danaher Corporation 83
11.4.1 Overview 83
11.4.2 Business Units 87
11.4.3 Geographic Revenue 88
11.4.4 Business Focus 89
11.4.5 SWOT Analysis 90
11.4.6 Business Strategies 90
11.5 Sysmex Corporation 91
11.5.1 Overview 91
11.5.2 Business Units 93
11.5.3 Geographic Revenue 95
11.5.4 Business Focus 95
11.5.5 SWOT Analysis 96
11.5.6 Business Strategies 96
12 Companies to Watch For 98
12.1 bioMerieux S.A. 98
12.1.1 Overview 98
12.2 Beckton Dickinson and Company 100
12.2.1 Overview 100
12.3 Bio-Rad Laboratories 102
12.3.1 Overview 102
12.4 Qiagen N.V. 104
12.4.1 Overview 104
12.5 Siemens Healthineers 109
12.5.1 Overview 109
12.6 Ortho Clinical Diagnostics (Carlyle Group) 112
12.6.1 Overview 112
13 Annexure 115
13.1 Abbreviations 115
List Of Figure
Charts
CHART 1 RESEARCH METHODOLOGY OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 13
CHART 2 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET REVENUE, 2018-2025 (USD BILLION) 16
CHART 3 SEGMENTATION OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 19
CHART 4 PEST ANALYSIS OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 19
CHART 5 PORTER 5 FORCES ON NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 20
CHART 6 MARKET DYNAMICS-DRO ANALYSIS 22
CHART 7 DRO-IMPACT ANALYSIS OF NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 25
CHART 8 KEY STAKEHOLDERS 26
CHART 9 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPES, 2018 (%) 28
CHART 10 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY TECHNOLOGY TYPES, 2025 (%) 28
CHART 11 CLINICAL CHEMISTRY MARKET FORECAST, 2018-2025 (USD BILLION) 30
CHART 12 MOLECULAR DIAGNOSTICS MARKET FORECAST, 2018-2025 (USD BILLION) 31
CHART 13 IMMUNOASSAY MARKET FORECAST, 2018-2025 (USD BILLION) 32
CHART 14 CLINICAL MICROBIOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 33
CHART 15 COAGULATION MARKET FORECAST, 2018-2025 (USD BILLION) 34
CHART 16 HEMATOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 35
CHART 17 OTHER IVD TECHNOLOGIES MARKET FORECAST, 2018-2025 (USD BILLION) 36
CHART 18 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION,
2018 (%) 37
CHART 19 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY APPLICATION SEGMENTATION,
2025 (%) 37
CHART 20 ONCOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 39
CHART 21 INFECTIOUS DISEASE MARKET FORECAST, 2018-2025 (USD BILLION) 40
CHART 22 DIABETES MARKET FORECAST, 2018-2025 (USD BILLION) 41
CHART 23 CARDIOLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 42
CHART 24 NEPHROLOGY MARKET FORECAST, 2018-2025 (USD BILLION) 43
CHART 25 AUTOIMMUNE DISEASE MARKET FORECAST, 2018-2025 (USD BILLION) 44
CHART 26 OTHER APPLICATIONS MARKET FORECAST, 2018-2025 (USD BILLION) 45
CHART 27 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY END-USERS SEGMENTATION,
2018 (%) 46
CHART 28 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY GEOGRAPHICAL SEGMENTATION,
2018 (%) 49
CHART 29 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET SHARE BY GEOGRAPHICAL SEGMENTATION,
2025 (%) 49
CHART 30 IN VITRO DIAGNOSTICS MARKET REVENUE IN THE US, 2018-2025 (USD BILLION) 52
CHART 31 IN VITRO DIAGNOSTICS MARKET REVENUE IN OTHERS, 2018-2025 (USD BILLION) 53
CHART 32 F. HOFFMANN-LA ROCHE LTD.: OVERVIEW SNAPSHOT 64
CHART 33 F. HOFFMANN-LA ROCHE LTD.: BUSINESS UNITS 64
CHART 34 F. HOFFMANN-LA ROCHE LTD.: GEOGRAPHIC REVENUE 65
CHART 35 F. HOFFMANN-LA ROCHE LTD.: SWOT ANALYSIS 66
CHART 36 THERMO FISHER SCIENTIFIC INC.: OVERVIEW SNAPSHOT 72
CHART 37 THERMO FISHER SCIENTIFIC INC.: BUSINESS UNITS 73
CHART 38 THERMO FISHER SCIENTIFIC INC.: GEOGRAPHIC REVENUE 74
CHART 39 THERMO FISHER SCIENTIFIC INC.: SWOT ANALYSIS 75
CHART 40 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 82
CHART 41 ABBOTT LABORATORIES: BUSINESS UNITS 83
CHART 42 ABBOTT LABORATORIES: GEOGRAPHIC REVENUE 84
CHART 43 ABBOTT LABORATORIES: SWOT ANALYSIS 85
CHART 44 DANAHER CORPORATION: OVERVIEW SNAPSHOT 90
CHART 45 DANAHER CORPORATION: BUSINESS UNITS 91
CHART 46 DANAHER CORPORATION: GEOGRAPHIC REVENUE 91
CHART 47 DANAHER CORPORATION: SWOT ANALYSIS 93
CHART 48 SYSMEX CORPORATION: OVERVIEW SNAPSHOT 96
CHART 49 SYSMEX CORPORATION: BUSINESS UNITS 96
CHART 50 SYSMEX CORPORATION: GEOGRAPHIC REVENUE 97
CHART 51 SYSMEX CORPORATION: SWOT ANALYSIS 98
List Of Table
Tables
TABLE 1 NORTH AMERICA IN VITRO DIAGNOSTICS MARKET REVENUE BY COUNTRIES,
2018-2025 (USD BILLION) 50
TABLE 2 OTHER PROMINENT VENDORS IN THE NORTH AMERICA IN VITRO DIAGNOSTICS MARKET 55
TABLE 3 F. HOFFMANN-LA ROCHE LTD.: PRODUCT OFFERINGS 57
TABLE 4 F. HOFFMANN-LA ROCHE LTD.: RECENT DEVELOPMENTS 62
TABLE 5 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 68
TABLE 6 THERMO FISHER SCIENTIFIC INC.: RECENT DEVELOPMENTS 70
TABLE 7 ABBOTT LABORATORIES: PRODUCT OFFERINGS 77
TABLE 8 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 78
TABLE 9 DANAHER CORPORATION: OFFERINGS 86
TABLE 10 DANAHER CORPORATION: RECENT DEVELOPMENTS 88
TABLE 11 SYSMEX CORPORATION: PRODUCT OFFERINGS 94
TABLE 12 SYSMEX CORPORATION: RECENT DEVELOPMENTS 95
TABLE 13 BIOMERIEUX S.A.: SNAPSHOT 100
TABLE 14 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 101
TABLE 15 BECTON DICKINSON AND COMPANY: SNAPSHOT 102
TABLE 16 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 103
TABLE 17 BIO-RAD LABORATORIES: SNAPSHOT 105
TABLE 18 BIO-RAD LABORATORIES: RECENT DEVELOPMENTS 106
TABLE 19 QIAGEN N.V.: SNAPSHOT 107
TABLE 20 QIAGEN N.V.: RECENT DEVELOPMENTS 107
TABLE 21 SIEMENS HEALTHINEERS: SNAPSHOT 113
TABLE 22 SIEMENS HEALTHINEERS: RECENT DEVELOPMENTS 113
TABLE 23 ORTHO CLINICAL DIAGNOSTICS (CARLYLE GROUP): SNAPSHOT 116
TABLE 24 ORTHO CLINICAL DIAGNOSTICS (CARLYLE GROUP): RECENT DEVELOPMENTS 116
?
"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Companies
Abbott Laboratories
Hoffmann-La Roche (Roche)
Thermo Fisher Scientific Inc.
Danaher Corporation
Sysmex Corporation
bioMerieux S.A.
Becton Dickinson and Company
Bio-Rad Laboratories
Qiagen N.V.
Siemens Healthineers
Ortho Clinical Diagnostics (Carlyle Group)